Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,572 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06902389RecruitingPhase 1/Phase 2
Multi-target immune cell therapy for advanced liver cancer
This trial tests a new type of immune cell therapy (multi-target Hi-TCR-T cells) for people with advanced liver cancer that hasn't responded to earlier treatments. The therapy targets several markers on your cancer cells to try to attack the tumor more effectively.
Shanghai, Yangpu DistrictAges 18–75 - NCT05862454Recruiting
Magnesium shots may help avoid steroid during certain immune health issues
This trial studies whether giving a magnesium injection can replace (or avoid) steroids during treatment around times of vaccine, a viral infection, or immune system weakness. It targets adults with long-term (chronic) pain who already receive injection-based treatments and can reliably track symptoms.
Surrey, British ColumbiaAges 20–99 - NCT06896617RecruitingPhase 4
Corpus Luteum's effect on frozen embryo transfer pregnancies
This study looks at whether having a corpus luteum (the structure left after an egg is released) affects pregnancy outcomes in frozen embryo transfer cycles. It aims to help doctors choose the best way to prepare the body for embryo transfer.
Barcelona, SpainAges 18–41 - NCT06748638Enrolling by invitationPhase 4
Lactulose and linaclotide for colonoscopy prep
This trial tests whether taking lactulose together with linaclotide can improve bowel cleansing before a colonoscopy. If you are scheduled for a colonoscopy, this study may help make the preparation more effective.
Nanjing, JiangsuAges 18–80 - NCT06895603Recruiting
New cuff to measure blood flow during heart procedures
This trial tests a new upper-arm cuff that may measure your heart's blood flow without needing an extra tube in your heart. If you already need a special heart catheter and a wrist arterial line, this study will see if the cuff works just as well.
Charlottesville, VirginiaAges 18 years+ - NCT06868147Recruiting
Long-term results of a second ACL reconstruction using a tendon graft
This study looks at people who had a second surgery to fix a torn ACL in their knee. The surgery used a special technique with a tendon from the Achilles. Researchers want to see how well the knee works and looks on X-rays at least 2 years after that surgery.
BolognaAges 18–50 - NCT05856370Recruiting
Study for follow-up of Medtronic spine or skull devices
This study checks how well certain Medtronic devices for the skull or spine are working in real-world care. If you’re getting one of these devices, you may be asked to do scheduled follow-up visits and assessments to confirm safety and performance.
Tucson, ArizonaAges 18 years+ - NCT05868434Recruiting
Surgery for unstable kneecap after dislocation
This trial looks at a surgical repair to stop a kneecap (patella) that keeps slipping out of place after a lateral dislocation. It’s intended for people whose symptoms did not improve with non-surgical treatments.
Bełchatów, Łódź VoivodeshipAges 18 years+ - NCT06899906Recruiting
Dalbavancin as long-term infection control: a safety study
This study looks back at patients who received the antibiotic dalbavancin as a long-term suppressive therapy for stubborn infections. It aims to see how well it worked and if it was safe.
France, LyonAges Any age - NCT06868836RecruitingPhase 2
Study of a new antibody combination for advanced lung cancer after targeted therapy
This trial tests a new drug (JS207) that targets both PD-1 and VEGF pathways, given alone or with other treatments, for people with advanced non-small cell lung cancer that has a specific gene change and has stopped responding to targeted therapy (TKI). The goal is to see if this combination can help shrink tumors or slow cancer growth.
Guangzhou, GuangdongAges 18–75 - NCT05116176Enrolling by invitation
Study of experiences after getting an ICD for heart protection
This study follows people who are scheduled to get a new ICD (a device that helps protect the heart) and asks about their experiences and quality of life. It may help doctors understand what patients feel and how people do after ICD implantation.
Boston, MassachusettsAges 65 years+ - NCT07451210Recruiting
Blood flow restriction therapy after ankle ligament surgery
This study tests whether a special blood flow restriction device used during physical therapy helps people recover better after ankle ligament repair. You would do physical therapy as usual, but with a cuff on your upper leg that gently limits blood flow during exercises, which may help strengthen muscles more quickly.
Lubbock, TexasAges 18–65 - NCT06839274Recruiting
Follicle size and egg maturity in poor responders
This trial looks at how the size of ovarian follicles (fluid sacs that contain eggs) affects egg maturity in women who have a low egg count. It may help improve egg freezing or IVF success.
Abu Dhabi, Abu Dhabi EmirateAges 18–48 - NCT06223841RecruitingPhase 1/Phase 2
Testing IAP0971 for advanced solid tumors and lung cancer
This trial tests a new drug, IAP0971, in patients with advanced solid tumors or a specific type of lung cancer (non-small cell lung cancer, or NSCLC) that has high PD-L1 levels. It aims to see if the drug can help when standard treatments have stopped working or are not an option.
Beijing, Beijing MunicipalityAges 18–75 - NCT07151859Recruiting
Skin hydration trial for face, neck, or chest
This study tests a polynucleotide-based injection to improve skin hydration in one area of the face, neck, or chest. It may be an option if you have healthy skin and are looking for a non-surgical way to boost moisture.
Naples, ItalyAges 18–70 - NCT06211647RecruitingPhase 1
177Lu XT117 for advanced solid tumors
This trial tests a new radioactive drug, [177Lu]Lu-XT117, that seeks out and delivers radiation to solid tumors that have a specific marker called FAP. It's for people whose cancer has not responded to other treatments or who have no other options.
BeijingAges 18 years+ - NCT03925701RecruitingPhase 3
Vildagliptin, with or without metformin, for fatty liver and diabetes
This trial studies how vildagliptin compares to vildagliptin plus metformin in people who have fatty liver disease along with type 2 diabetes. It may help find the safest and most effective way to improve liver health and diabetes control.
TantaAges 18 years+ - NCT06827665RecruitingPhase 1/Phase 2
Dentin Bone Graft for Jawbone Preservation After Tooth Extraction
This trial tests a new type of bone graft made from donated teeth to help preserve the jawbone after multiple teeth are pulled. It aims to see if this natural material helps the bone heal better than standard treatments.
AmmanAges 18–60 - NCT05887557Recruiting
Mobile HIV care for people struggling to stay in treatment
This study tests a low-barrier, mobile HIV care program designed with input from patients and other stakeholders to help people stay engaged in care and reach an undetectable viral load. It may help if you’re having trouble keeping regular HIV appointments or staying on treatment.
Oakland, CaliforniaAges 15 years+ - NCT06239818Recruiting
Light therapy for concussion recovery in teens
This trial tests whether a special light therapy (photobiomodulation) can help teenagers recover faster from a sports-related concussion. If you qualify, you will receive the light treatment in addition to your usual care, and researchers will track your symptoms and thinking skills over time.
Houston, TexasAges 13–18 - NCT05893030Recruiting
Monitoring pain and sleep medicines to prevent complications after surgery
This study looks at whether closely monitoring opioid and sleep medicines during and after surgery can lower organ problems and death in older adults at high risk. If you qualify, your team will track how these medicines are given to help keep you safer in the postoperative period.
AmiensAges 75 years+ - NCT06683885RecruitingPhase 1/Phase 2
Targeted drug combo for elderly DLBCL patients
This trial tests a combination of targeted drugs (Obutinib or Decitabine) with standard chemo (Rituximab, Cyclophosphamide, Prednisone) for elderly patients with newly diagnosed diffuse large B-cell lymphoma who cannot handle full-dose chemotherapy. The goal is to see if this approach is safer and works as well.
Zhengzhou, HenanAges 65 years+ - NCT06808724Recruiting
Effect of implant surface treatment on stability
This trial compares how different surface treatments on dental implants affect their stability. It is for people who need implants in both upper premolar/molar areas and have healed enough bone without grafts.
Trieste, TSAges 18 years+ - NCT07401758Recruiting
Shockwave therapy for knee tendon pain
This study tests whether a noninvasive treatment called shockwave therapy can help reduce pain and improve function in people with patellar tendinitis, a common overuse injury of the knee tendon. It may be a good option for you if you have moderate knee pain and are otherwise healthy.
Guangzhou, GuangdongAges 18–45
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,572 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.